Baudax Bio, Inc.
BXRXQ
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 73.78% | -164.67% | 223.29% | 68.33% | -287.81% |
| Total Depreciation and Amortization | 13,000.00% | -66.67% | -92.50% | 344.44% | -40.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -235.13% | 115.80% | -370.69% | -75.83% | 488.70% |
| Change in Net Operating Assets | 333.18% | -15.83% | 230.81% | -188.79% | 235.15% |
| Cash from Operations | 42.16% | -5.94% | -4.10% | 2.70% | 72.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | -114.79% | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 77.08% | -118.18% | 2.83% | -35.73% | -200.00% |
| Issuance of Common Stock | -42.04% | -19.27% | -8.54% | -11.72% | 221.54% |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 46.89% | -785.00% | 90.24% | -2.50% | 79.74% |
| Cash from Financing | 50.60% | -71.42% | -5.51% | -21.50% | 975.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 200.00% | -- | -- | -- |
| Net Change in Cash | 55.89% | -63.94% | -275.26% | -188.79% | 106.92% |